Inflammation in ALS and SMA: Sorting out the good from the evil
- 31 March 2010
- journal article
- review article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 37 (3), 493-502
- https://doi.org/10.1016/j.nbd.2009.10.005
Abstract
No abstract availableThis publication has 127 references indexed in Scilit:
- The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosisAnnals of Neurology, 2008
- HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsBrain Research, 2008
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degenerationNature Neuroscience, 2008
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicityNeuroscience, 2007
- D-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Pro-NGF secreted by astrocytes promotes motor neuron cell deathMolecular and Cellular Neuroscience, 2007
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006
- The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis miceProceedings of the National Academy of Sciences of the United States of America, 2006